AstraZeneca to begin $4.5 billion Virginia facility expands U.S. drug manufacturing
The manufacturing facility is expected to create 3,600 jobs WILMINGTON: AstraZeneca is investing $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500 million to support the enhanced manufacturing capability of a broader range of medicines including cancer treatments. This is part of the historic $50 billion investment announced in July…